Efficacy News and Research

RSS

Spikevax approved for use in children aged 6 months to 5 years

Spikevax, the COVID-19 vaccine from Moderna, has today been authorized for use in children aged 6 months to 5 years.

9 May 2023

Most effective treatment for excessive daytime sleepiness found

McMaster University researchers Dena Zeraatkar and Tyler Pitre have found that the drug solriamfetol is the most effective treatment for excessive daytime sleepiness (EDS) for people with obstructive sleep apnea (OSA).

9 May 2023

New small-molecule drugs show potential clinical utility in treating world’s leading causes of blindness

In a University of California, Irvine-led study, researchers have discovered small-molecule drugs with potential clinical utility in the treatment of age-related macular degeneration (AMD), diabetic retinopathy (DR), and retinitis pigmentosa (RP).

9 May 2023

Legal pot is more potent than ever — and still largely unregulated

Marijuana and other products containing THC, the plant's main psychoactive ingredient, have grown more potent and more dangerous as legalization has made them more widely available.

9 May 2023

Differences in genetics, lifestyle factors likely have unique effects on CVD risk in Asian Americans

Asian Americans have significant differences in genetics, socioeconomic factors, culture, diet, lifestyle, health interventions and acculturation levels based on the Asian region of their ancestry that likely have unique effects on their risk for heart disease and Type 2 diabetes, according to a new American Heart Association scientific statement published today in the Association's flagship, peer-reviewed journal Circulation.

8 May 2023

Waco COVID Survey provides insights into the dynamics of COVID-19 transmission, health behaviors

Results from the Waco COVID Survey have provided needed insights into how the dynamics of COVID-19 transmission, health behaviors and COVID-19-related attitudes changed across the first two years of the pandemic in the McLennan County, Texas.

8 May 2023

Cognitive behavioral therapy is beneficial for individuals with post-viral fatigue after COVID-19

Those with post-viral fatigue after suffering from COVID-19 benefit from cognitive behavioral therapy, resulting in less fatigue and concentration problems.

8 May 2023

Intratumoral bacteria linked with natural purple photosynthetic bacteria show strong anticancer efficacy

Cancer remains one of the leading causes of death worldwide. Researchers are constantly looking for new therapies with improved anticancer activity, fewer side effects, and lower costs.

8 May 2023

Anticoronavirals: the development of COVID-19 therapies and the challenges that remain

Researchers highlighted the pace of development of COVID-19 therapies during the pandemic and the challenges that hinder the widespread availability of anticoronavirals.

8 May 2023

First CRISPR-armed phage therapeutic can specifically target and remove E. coli in the human gut

SNIPR Biome ApS ("SNIPR"), the company pioneering CRISPR-based microbial gene therapy, announces today that Nature Biotechnology has published research findings from its preclinical work on SNIPR001, the first CRISPR-armed phage therapeutic developed to specifically target and remove E. coli, including antibiotic-resistant strains, in the human gastrointestinal tract.

8 May 2023

The safety and efficacy of FINLAY-FR-2/1A, a new protein-based COVID-19 vaccine

Research paper reports the results of a phase 3 clinical trial evaluating the efficacy and safety of the FINLAY-FR-2 and FINLAY-FR-1A vaccines in Iranian adults.

7 May 2023

Study shows MPXV can persist on surfaces for extended periods, but can be inactivated by alcohol-based disinfectants

Researcher evaluates the stability of monkeypox virus (MPXV) on stainless steel surfaces stored at different temperatures and using different interfering substances to mimic environmental contamination.

7 May 2023

Breast cancer tumors disrupt the development of an immune response to favor their own growth

Researchers at Baylor College of Medicine and collaborating institutions have identified a strategy cancerous tumors use to remotely disrupt the development of an immune response that could stop their growth.

5 May 2023

Team successfully treats aggressive vascular malformation in an infant's brain before birth

In a first, a team from Brigham and Women's Hospital and Boston Children's Hospital successfully treated an aggressive vascular malformation in an infant's brain before birth, avoiding potentially fatal symptoms after delivery.

5 May 2023

Cannabis product authenticity: a metabolomic big data approach

Researchers examined the aspects of the authentomics of cannabis products.

5 May 2023

Did race/ethnicity disparities in severe COVID-19 outcomes persist in the era of vaccination?

Researchers evaluated whether race disparities in COVID-19 severity outcomes were persistent.

5 May 2023

Researchers perform in-utero surgery to repair a potentially deadly developmental condition

For the first time, researchers performed a successful in-utero surgery to repair a potentially deadly developmental condition by treating an aggressive vascular malformation, called vein of Galen malformation, in a fetus's brain before birth, according to new research published today in Stroke, the peer-reviewed flagship journal of the American Stroke Association, a division of the American Heart Association.

5 May 2023

Evaluating the effectiveness of both BA.1-containing and BA.4/BA.5-containing bivalent COVID-19 mRNA vaccines

Researchers evaluated the effectiveness, in absolute and relative terms, of vaccines.

5 May 2023

Medical cannabis soothes cancer pain

Study evaluated the safety and effectiveness of medical cannabis in reducing pain and concurrent medications in patients with cancer. The results suggest that medical cannabis is a safe and effective complementary treatment for pain relief in patients with cancer.

4 May 2023

Study pinpoints how gut microbes boost the body's response to cancer immunotherapy

Cancer immunotherapy has transformed the treatment of many types of cancer. Yet, for reasons that remain poorly understood, not all patients get the same benefit from these powerful therapies.

4 May 2023

Efficacy News and Research

Spikevax approved for use in children aged 6 months to 5 years

Most effective treatment for excessive daytime sleepiness found

New small-molecule drugs show potential clinical utility in treating world’s leading causes of blindness

Legal pot is more potent than ever — and still largely unregulated

Differences in genetics, lifestyle factors likely have unique effects on CVD risk in Asian Americans

Waco COVID Survey provides insights into the dynamics of COVID-19 transmission, health behaviors

Cognitive behavioral therapy is beneficial for individuals with post-viral fatigue after COVID-19

Intratumoral bacteria linked with natural purple photosynthetic bacteria show strong anticancer efficacy

Anticoronavirals: the development of COVID-19 therapies and the challenges that remain

First CRISPR-armed phage therapeutic can specifically target and remove E. coli in the human gut

The safety and efficacy of FINLAY-FR-2/1A, a new protein-based COVID-19 vaccine

Study shows MPXV can persist on surfaces for extended periods, but can be inactivated by alcohol-based disinfectants

Breast cancer tumors disrupt the development of an immune response to favor their own growth

Team successfully treats aggressive vascular malformation in an infant's brain before birth

Cannabis product authenticity: a metabolomic big data approach

Did race/ethnicity disparities in severe COVID-19 outcomes persist in the era of vaccination?

Researchers perform in-utero surgery to repair a potentially deadly developmental condition

Evaluating the effectiveness of both BA.1-containing and BA.4/BA.5-containing bivalent COVID-19 mRNA vaccines

Medical cannabis soothes cancer pain

Study pinpoints how gut microbes boost the body's response to cancer immunotherapy

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News